AACE 2019

Cardiovascular Effects of Canagliflozin Vary According to Concomitant Metformin Use

By

Amit Akirov, MD

Publish Date April 27, 2019 1:35 pm

The cardiovascular and renal effects of treatment with canagliflozin in patients with type 2 diabetes are more prominent in patients not taking metformin compared with patients treated with canagliflozin as an add-on to metformin.

Social Determinants of Health Affect the Care Experience of Overweight Patients

By

Madeline Morr

Publish Date April 27, 2019 1:05 pm

Patients reported barriers to care including social determinants of health in obesity management by their healthcare provider.

Newly Identified Ultrasound Characteristic May Predict Thyroid Nodule Malignancy Risk

By

Amit Akirov, MD

Publish Date April 26, 2019 3:35 pm

In indeterminate thyroid nodules, evidence of thick post-microcystic reflection on ultrasound was found to be associated with malignant nodules.

Teprotumumab Effectively Reduces Proptosis in Active Thyroid Eye Disease

By

Rachael Beairsto

Publish Date April 26, 2019 2:05 pm

Teprotumumab effectively reduces proptosis in patients with active thyroid eye disease.

Hypothyroidism a Risk Factor for Mortality in Congestive Heart Failure

By

Nicole Clemons

Publish Date April 26, 2019 2:05 pm

Hypothyroidism is a risk factor for increased length of hospital stay and mortality in patients with congestive heart failure.

Novel Cardiometabolic Staging Tool Predicts T2D Risk in Diverse Population

By

Kwamesha Joseph

Publish Date April 26, 2019

A weighted cardiometabolic disease staging risk score can be used to quantify race- and sex-specific type 2 diabetes risk in a large, diverse population.

Anxiety More Common Than Depression in Euthyroid Patients With Thyroid Disease

By

Laurell Haapanen

Publish Date April 25, 2019 4:35 pm

Although hypothyroidism is linked to depression, anxiety is the main complaint of euthyroid patients with thyroid disease, with or without Hashimoto thyroiditis.

Levoketoconazole Improves Biochemical and Clinical Parameters in Patients With Cushing Syndrome

By

Amit Akirov, MD

Publish Date April 25, 2019 3:35 pm

Biochemical markers and clinical signs and symptoms of endogenous Cushing syndrome improved after 6 months of levoketoconazole therapy.

Cortisol Pumps May Be Viable Option to Reduce Adrenal Crisis in Severe Adrenal Insufficiency

By

Amit Akirov, MD

Publish Date April 25, 2019 3:35 pm

The use of insulin pump to deliver continuous pulsatile cortisol may be a viable treatment option in patients with severe adrenal insufficiency who are unresponsive to oral corticosteroids.

Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D

By

Amit Akirov, MD

Publish Date April 25, 2019 3:05 pm

Abaloparatide followed by alendronate treatment may improve bone mineral density in women with postmenopausal osteoporosis and type 2 diabetes.

Linagliptin Does Not Increase Adverse Renal Events in Patients With T2D, Kidney Disease

By

Amit Akirov, MD

Publish Date April 25, 2019 3:05 pm

Treatment with linagliptin in patients with type 2 diabetes and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events.

Type 2 Diabetes Associated With Short-Term Risk for Fracture

By

Amit Akirov, MD

Publish Date April 25, 2019 2:05 pm

Type 2 diabetes is associated with increased risk for fractures in the short term but not in the long term.